Hugo Masson

Hugo Masson serves as the Director of Launch and Product Management at Alvotech, where responsibilities include leading global teams in the late development and life-cycle management of biosimilars in various markets. Prior experience includes roles at Viatris, where Hugo progressed to Senior Launch Manager, overseeing the launch of biosimilars in Europe, and at Boehringer Ingelheim as Global Industrial Strategy Coordinator, focusing on strategic analysis and project management during the merger with Merial. Earlier positions at Merial encompassed project management for vaccine initiatives and global marketing coordination. Hugo holds an Advanced Master in Business Administration from Grenoble Ecole de Management and a Doctor of Pharmacy from Université Claude Bernard Lyon 1.